Effects of the phytotheraputic preparation Circulat on gene expression levels in cultured human fibroblasts were determined using whole-genome microarray analysis. Circulat is a systemic herbal formulation that was developed under the postulates of the Systemic Theory at Centro Médico Docente Adaptógeno de Venezuela, where it is practically used, in cooperation with Nulab Inc., USA .
Lyophilized Circulat water extract was added to the culture media to a final concentration of 2 mcg per ml and human fibroblast cells MRC-5 were cultured at 37 °C for 16 hours. Control fibroblasts were cultured in parallel under same conditions without the extract. Upon treatment, total RNA was isolated from the cells and used for microarray analysis. Both Circulat-treated and control experiments were carried out in triplicates yielding six samples that were processed independently.
Microarray analysis was performed in accordance with standard procedures recommended by Affymetrix, Inc using Affymetrix GeneChip Human Genome U133 Plus 2.0 arrays. U133 Plus 2.0 arrays provide full genomic coverage and contain probes for more than 47,000 unique transcripts corresponding to more than 38,500 human genes. Following hybridization and scanning, raw data in the form of image files were converted to gene expression values using Affymetrix GeneChip Operating Software (GCOS). GCOS utilizes MAS 5.0 algorithm for data normalization, background subtraction, estimation of nonspecific binding, calculation of detection p-values, and generation of "presence" calls. Two-tailed Student's t-test assuming unequal sample variance was used to identify genes that displayed significant changes in the mean expression levels between control and treated samples with the t-test p-value less then 0.05. Only probes that were called "present" in at least two samples were considered in this analysis. In order to identify strongly regulated genes, we imposed an additional requirement for the mean fold change between the samples to be no less then 2. 52 genes satisfied these stringent criteria demonstrating that Circulate treatment resulted in significant changes in gene expression levels.
38 genes were upregulated, i.e. their expression levels were increased, and 14 genes were downregulated, i.e. their expression levels were decreased upon Circulat treatment by at least two fold. Downregulation does not mean a negative effect since positive effects of some drugs or stimuli are produced by the reduction of expression levels and activities of certain genes. The complete list of Circulat-responsive genes with mean expression values, fold change, t-test statistics, proteins encoded by them, brief descriptions of biological processes they participate in, molecular functions attributed to them, their likely subcellular localization as well as some other characteristics can be found in the attached supplement.
Clinical observations have firmly established that Circulat prevents development of severe manifestations of Type 2 diabetes. It is quite likely therefore, that at list some of the genes identified by our analysis as being regulated by Circulat are involved in pathogenesis or susceptibility to Type 2 diabetes. The obtained results provide an excellent opportunity to discover genes involved in the onset of Type 2 diabetes, which is the necessary prerequisite for our in-depth understanding of the disease as well as for development of new drugs and treatments. They also reveal the previously unknown molecular mechanisms of Circulat action and demonstrate the great potential of this preparation for normalization of gene expression altered in Type 2 diabetic patients.
Our analysis indicates that a large proportion of the identified genes are involved in energy metabolism and signaling pathways. This is consistent with what is currently known about molecular changes underlying Type 2 diabetes. Further analysis of these genes may reveal novel pathways involved in the disease development and progression and may yield new molecular targets for drug development. Several of likely candidates are listed below:
RTP1 receptor transporting protein 1
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4
RABGAP1L RAB GTPase activating protein 1-like
NMNAT2 nicotinamide nucleotide adenylyltransferase 2
STK38 serine/threonine kinase 38
ATF71P2 activating transcription factor 7 interacting protein 2
CH25H cholesterol 25-hydroxylase
GRK6 G protein-coupled receptor kinase 6
TMEM26 transmembrane protein 26
TRPM2 transient receptor potential cation channel, subfamily M, member 2.
It is important to point out that TRPM2 gene has been previously shown to be involved in the process of development of atherosclerosis, which is known to contribute to the pathogenesis of Type 2 diabetes. The observed reduction of expression levels of this gene by Circulat, therefore, is likely to be one of the main determinants of the positive effect of the preparation.
Microarray analysis is a new and extremely powerful technique that has been made possible by the latest achievements of molecular genetics and nanotechnology. It allows one to precisely monitor changes that take place inside the organism upon drug treatment on the molecular level and offers an objective way of estimating drug efficacy. This is the first study in which microarray analysis was used to reveal genome-wide expression changes in cultured human cells upon their treatment with a herbal preparation and it demonstrated the potential of such an approach for future development of herbal medicine.
Tissue culture work and microarray analyses were performed in DNA Sequencing Facility and Microarray Core Facility of the University of Pennsylvania School of Medicine, respectively.
Gene Symbols and Expression Data
Gene Symbol |
Affymetrix Probe Id |
Mean Experiment |
Mean Control |
Fold Change |
t-test p-value |
RTP1 |
1553823_a_at |
15.66666667 |
3.166666667 |
4.947368421 |
0.006920496 |
CYP3A4 |
205998_x_at |
90.63333333 |
20.8 |
4.357371795 |
0.010950177 |
CA12 |
233388_at |
29.03333333 |
6.666666667 |
4.355 |
0.012863121 |
RABGAP1L |
237650_at |
36.46666667 |
8.6 |
4.240310078 |
0.008981609 |
NMNAT2 |
1556029_s_at |
20.86666667 |
5.133333333 |
4.064935065 |
0.042171054 |
RLTPR |
227216_at |
32.6 |
9 |
3.622222222 |
0.024903156 |
CCL5 |
204655_at |
33.86666667 |
9.6 |
3.527777778 |
0.033727623 |
GLYAT |
206930_at |
24.23333333 |
7.766666667 |
3.120171674 |
0.041978624 |
ZC3H12C |
1559763_at |
19.93333333 |
6.4 |
3.114583333 |
0.030189001 |
CEACAM6 |
211657_at |
26.66666667 |
8.766666667 |
3.041825095 |
0.03325915 |
AHI1 |
220842_at |
23 |
8.133333333 |
2.827868852 |
0.025509932 |
CYLC1 |
216809_at |
25.83333333 |
9.3 |
2.777777778 |
0.004057367 |
FLJ20211 |
229864_at |
64.7 |
24.93333333 |
2.594919786 |
0.046694254 |
AOF2 |
1555897_at |
42.83333333 |
16.53333333 |
2.590725806 |
0.01310035 |
MGC40368 |
1569206_at |
50.83333333 |
20.23333333 |
2.512355848 |
0.023463147 |
KIAA0690 |
1559127_x_at |
56.13333333 |
22.53333333 |
2.49112426 |
0.048737734 |
SIRT2 |
1558331_at |
33.96666667 |
13.76666667 |
2.467312349 |
0.028619776 |
NUP210 |
212316_at |
42.06666667 |
17.06666667 |
2.46484375 |
0.043021154 |
OLFM2 |
223601_at |
36.8 |
15.26666667 |
2.410480349 |
0.043482934 |
KIAA0802 |
240448_at |
28.36666667 |
11.83333333 |
2.397183099 |
0.019624743 |
STXBP3 |
1560486_at |
22.4 |
9.366666667 |
2.391459075 |
0.028410646 |
ULK1 |
209333_at |
43.16666667 |
18.06666667 |
2.389298893 |
0.014691051 |
MGC39558 |
1562391_at |
35.56666667 |
14.93333333 |
2.381696429 |
0.031269169 |
SETBP1 |
236317_at |
33.4 |
14.03333333 |
2.380047506 |
0.046771831 |
KIAA1609 |
233423_at |
29.03333333 |
12.26666667 |
2.366847826 |
0.049702477 |
ZBTB7A |
219186_at |
58.3 |
26.03333333 |
2.23943662 |
0.003884894 |
MAPT |
206401_s_at |
33.03333333 |
15.03333333 |
2.197339246 |
0.019562624 |
ANXA2P3 |
211241_at |
162 |
73.96666667 |
2.190175755 |
0.035526956 |
ZBTB20 |
240216_at |
35.76666667 |
16.53333333 |
2.163306452 |
0.040516242 |
FLJ40722 |
1564028_s_at |
48.8 |
23.23333333 |
2.100430416 |
0.003223983 |
DYM |
220774_at |
34.5 |
16.43333333 |
2.099391481 |
0.007879413 |
NEURL |
204888_s_at |
33.3 |
15.86666667 |
2.098739496 |
0.049228493 |
OR2A9P /// OR2A20P |
223971_at |
40.76666667 |
19.46666667 |
2.094178082 |
0.043374012 |
CDYL |
240594_at |
38.33333333 |
18.5 |
2.072072072 |
0.040712976 |
STK38 |
244679_at |
32.36666667 |
15.63333333 |
2.070362473 |
0.029048526 |
ATF7IP2 |
219870_at |
38.2 |
18.76666667 |
2.035523979 |
0.01364187 |
MAF |
209348_s_at |
22.36666667 |
11.06666667 |
2.021084337 |
0.040223685 |
RP1-32F7.2 |
239481_at |
19.8 |
9.833333333 |
2.013559322 |
0.029458491 |
DKFZp434D1428 |
223409_at |
17.53333333 |
35.36666667 |
0.495758718 |
0.012493312 |
TIFA |
238858_at |
13.16666667 |
27.33333333 |
0.481707317 |
0.013270711 |
EVI2B |
211742_s_at |
19 |
39.5 |
0.481012658 |
0.044037999 |
CH25H |
206932_at |
14 |
29.56666667 |
0.473506201 |
0.021032921 |
GRK6 |
210981_s_at |
44.86666667 |
95.96666667 |
0.467523446 |
0.00649051 |
DKK2 |
224199_at |
7.033333333 |
16.03333333 |
0.438669439 |
0.049259205 |
TMEM26 |
1555025_at |
8.266666667 |
19.26666667 |
0.429065744 |
0.044468546 |
WDR68 |
236134_at |
11.63333333 |
28 |
0.41547619 |
0.013415944 |
ZFHX1B |
1557797_a_at |
13.63333333 |
33.4 |
0.408183633 |
0.028878705 |
MGC10986 |
218600_at |
18.26666667 |
45.1 |
0.405025868 |
0.003551854 |
C21orf37 |
240801_at |
7.333333333 |
18.83333333 |
0.389380531 |
0.026918272 |
TRPM2 |
205708_s_at |
18.36666667 |
48.33333333 |
0.38 |
0.025004711 |
NIPSNAP3B |
223764_x_at |
5.666666667 |
15.9 |
0.35639413 |
0.040051049 |
FHL5 |
1555191_a_at |
4.566666667 |
14.8 |
0.308558559 |
0.022784303 |
Gene Descriptions
Gene Symbol |
Gene Description |
RTP1 |
receptor transporting protein 1 |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
CA12 |
Carbonic anhydrase XII |
RABGAP1L |
RAB GTPase activating protein 1-like |
NMNAT2 |
nicotinamide nucleotide adenylyltransferase 2 |
RLTPR |
RGD, leucine-rich repeat, tropomodulin and proline-rich containing protein |
CCL5 |
chemokine (C-C motif) ligand 5 /// chemokine (C-C motif) ligand 5 |
GLYAT |
glycine-N-acyltransferase |
ZC3H12C |
zinc finger CCCH-type containing 12C |
CEACAM6 |
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) |
AHI1 |
Abelson helper integration site |
CYLC1 |
cylicin, basic protein of sperm head cytoskeleton 1 |
FLJ20211 |
Hypothetical protein FLJ20211 |
AOF2 |
amine oxidase (flavin containing) domain 2 |
MGC40368 |
T-complex 11 (mouse) like 2 |
KIAA0690 |
KIAA0690 |
SIRT2 |
Sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae) |
NUP210 |
nucleoporin 210kDa |
OLFM2 |
olfactomedin 2 |
KIAA0802 |
KIAA0802 |
STXBP3 |
syntaxin binding protein 3 |
ULK1 |
unc-51-like kinase 1 (C. elegans) |
MGC39558 |
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 2 |
SETBP1 |
SET binding protein 1 |
KIAA1609 |
KIAA1609 protein |
ZBTB7A |
zinc finger and BTB domain containing 7A |
MAPT |
microtubule-associated protein tau |
ANXA2P3 |
annexin A2 pseudogene 3 |
ZBTB20 |
Zinc finger and BTB domain containing 20 |
FLJ40722 |
hypothetical protein FLJ40722 |
DYM |
Dymeclin |
NEURL |
neuralized-like (Drosophila) |
OR2A9P /// OR2A20P |
olfactory receptor, family 2, subfamily A, member 20 pseudogene |
CDYL |
Chromodomain protein, Y-like |
STK38 |
Serine/threonine kinase 38 |
ATF7IP2 |
activating transcription factor 7 interacting protein 2 |
MAF |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) |
RP1-32F7.2 |
hypothetical protein FLJ37659 |
DKFZp434D1428 |
hypothetical protein DKFZp434D1428 |
TIFA |
TRAF-interacting protein with a forkhead-associated domain |
EVI2B |
ecotropic viral integration site 2B |
CH25H |
cholesterol 25-hydroxylase |
GRK6 |
G protein-coupled receptor kinase 6 |
DKK2 |
dickkopf homolog 2 (Xenopus laevis) |
TMEM26 |
transmembrane protein 26 |
WDR68 |
WD repeat domain 68 |
ZFHX1B |
Zinc finger homeobox 1b |
MGC10986 |
hypothetical protein MGC10986 |
C21orf37 |
chromosome 21 open reading frame 37 |
TRPM2 |
transient receptor potential cation channel, subfamily M, member 2 |
NIPSNAP3B |
nipsnap homolog 3B (C. elegans) |
FHL5 |
four and a half LIM domains 5, activator of CREM in testis |
Biological Process Summary
Gene Symbol |
Gene Ontology Biological Process Description |
RTP1 |
--- |
CYP3A4 |
electron transport /// lipid metabolism /// xenobiotic metabolism /// xenobiotic metabolism |
CA12 |
one-carbon compound metabolism |
RABGAP1L |
--- |
NMNAT2 |
biosynthesis /// NAD biosynthesis /// pyridine nucleotide biosynthesis |
RLTPR |
--- |
CCL5 |
calcium ion homeostasis /// exocytosis /// cell motility /// chemotaxis /// inflammatory response /// cellular defense response /// response to oxidative stress /// cell adhesion /// signal transduction /// cell-cell signaling /// sensory perception /// response to virus /// chemotaxis /// inflammatory response /// immune response /// immune response |
GLYAT |
acyl-CoA metabolism /// response to toxin |
ZC3H12C |
--- |
CEACAM6 |
signal transduction /// cell-cell signaling |
AHI1 |
--- |
CYLC1 |
spermatogenesis /// cell differentiation /// development /// spermatogenesis |
FLJ20211 |
--- |
AOF2 |
electron transport /// transcription /// regulation of transcription, DNA-dependent /// chromatin modification |
MGC40368 |
--- |
KIAA0690 |
--- |
SIRT2 |
chromatin silencing at rDNA /// chromatin silencing at telomere /// regulation of transcription, DNA-dependent /// protein amino acid ADP-ribosylation /// redox signal response /// cell cycle /// mitosis /// regulation of exit from mitosis /// negative regulation of transcription /// histone deacetylation /// regulation of phosphorylation /// negative regulation of striated muscle development /// cell division /// redox signal response /// regulation of exit from mitosis /// negative regulation of transcription /// histone deacetylation /// regulation of phosphorylation /// negative regulation of striated muscle development /// chromatin silencing /// chromatin silencing /// gene silencing |
NUP210 |
--- |
OLFM2 |
--- |
KIAA0802 |
--- |
STXBP3 |
vesicle docking during exocytosis /// protein transport /// vesicle-mediated transport /// transport |
ULK1 |
protein amino acid phosphorylation /// signal transduction /// protein amino acid phosphorylation |
MGC39558 |
protein amino acid glycosylation |
SETBP1 |
--- |
KIAA1609 |
--- |
ZBTB7A |
transcription /// negative regulation of transcription, DNA-dependent /// cartilage development /// regulation of transcription, DNA-dependent |
MAPT |
microtubule cytoskeleton organization and biogenesis /// apoptosis /// negative regulation of microtubule depolymerization /// negative regulation of microtubule depolymerization |
ANXA2P3 |
--- |
ZBTB20 |
transcription /// regulation of transcription, DNA-dependent |
FLJ40722 |
--- |
DYM |
--- |
NEURL |
nervous system development /// protein ubiquitination |
OR2A9P /// OR2A20P |
G-protein coupled receptor protein signaling pathway |
CDYL |
chromatin assembly or disassembly /// spermatogenesis /// metabolism |
STK38 |
protein amino acid phosphorylation /// protein kinase cascade /// protein modification /// protein amino acid phosphorylation |
ATF7IP2 |
--- |
MAF |
transcription /// regulation of transcription, DNA-dependent /// transcription from RNA polymerase II promoter |
RP1-32F7.2 |
--- |
DKFZp434D1428 |
--- |
TIFA |
--- |
EVI2B |
--- |
CH25H |
metabolism /// lipid metabolism |
GRK6 |
protein amino acid phosphorylation /// signal transduction /// regulation of G-protein coupled receptor protein signaling pathway |
DKK2 |
development /// Wnt receptor signaling pathway /// negative regulation of Wnt receptor signaling pathway |
TMEM26 |
--- |
WDR68 |
--- |
ZFHX1B |
regulation of transcription, DNA-dependent /// nervous system development /// negative regulation of transcription /// transcription /// regulation of transcription |
MGC10986 |
--- |
C21orf37 |
--- |
TRPM2 |
cation transport /// sodium ion transport /// calcium ion transport /// transport /// ion transport /// calcium ion transport |
NIPSNAP3B |
--- |
FHL5 |
--- |
Molecular Function Summary
Gene Symbol |
Gene Ontology Molecular Function Description |
RTP1 |
--- |
CYP3A4 |
iron ion binding /// oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen /// oxygen binding /// heme binding /// metal ion binding /// unspecific monooxygenase activity /// quinine 3-monooxygenase activity /// monooxygenase activity /// monooxygenase activity /// oxidoreductase activity /// monooxygenase activity /// testosterone 6-beta-hydroxylase activity /// monooxygenase activity |
CA12 |
carbonate dehydratase activity /// zinc ion binding /// lyase activity /// metal ion binding /// carbonate dehydratase activity /// zinc ion binding |
RABGAP1L |
--- |
NMNAT2 |
nicotinamide-nucleotide adenylyltransferase activity /// transferase activity /// nucleotidyltransferase activity |
RLTPR |
--- |
CCL5 |
chemokine activity /// cytokine activity /// chemokine activity /// signal transducer activity /// receptor binding |
GLYAT |
acyltransferase activity /// transferase activity /// glycine N-acyltransferase activity /// acyltransferase activity |
ZC3H12C |
--- |
CEACAM6 |
receptor activity |
AHI1 |
--- |
CYLC1 |
structural molecule activity /// structural molecule activity |
FLJ20211 |
--- |
AOF2 |
oxidoreductase activity |
MGC40368 |
--- |
KIAA0690 |
Binding |
SIRT2 |
DNA binding /// transcription factor binding /// zinc ion binding /// hydrolase activity /// NAD-dependent histone deacetylase activity /// histone acetyltransferase binding /// histone deacetylase binding /// tubulin deacetylase activity /// ubiquitin binding /// metal ion binding /// protein binding /// transcription factor binding /// NAD-dependent histone deacetylase activity /// histone acetyltransferase binding /// histone deacetylase binding /// tubulin deacetylase activity /// ubiquitin binding /// zinc ion binding |
NUP210 |
porin activity /// protein binding |
OLFM2 |
latrotoxin receptor activity |
KIAA0802 |
--- |
STXBP3 |
--- |
ULK1 |
nucleotide binding /// protein serine/threonine kinase activity /// protein-tyrosine kinase activity /// protein binding /// ATP binding /// transferase activity /// protein kinase activity /// protein serine/threonine kinase activity /// kinase activity |
MGC39558 |
galactosyltransferase activity /// transferase activity |
SETBP1 |
DNA binding |
KIAA1609 |
--- |
ZBTB7A |
DNA binding /// protein binding /// zinc ion binding /// transcriptional repressor activity /// histone acetyltransferase binding /// metal ion binding /// nucleic acid binding /// DNA binding |
MAPT |
structural constituent of cytoskeleton |
ANXA2P3 |
--- |
ZBTB20 |
DNA binding /// protein binding /// zinc ion binding /// metal ion binding /// nucleic acid binding |
FLJ40722 |
--- |
DYM |
--- |
NEURL |
ubiquitin-protein ligase activity /// zinc ion binding /// metal ion binding |
OR2A9P /// OR2A20P |
rhodopsin-like receptor activity /// olfactory receptor activity |
CDYL |
chromatin binding /// catalytic activity |
STK38 |
nucleotide binding /// magnesium ion binding /// protein serine/threonine kinase activity /// protein-tyrosine kinase activity /// ATP binding /// transferase activity /// magnesium ion binding /// protein kinase activity /// protein serine/threonine kinase activity /// ATP binding /// kinase activity /// metal ion binding |
ATF7IP2 |
--- |
MAF |
DNA binding /// RNA polymerase II transcription factor activity |
RP1-32F7.2 |
--- |
DKFZp434D1428 |
--- |
TIFA |
--- |
EVI2B |
--- |
CH25H |
catalytic activity /// steroid hydroxylase activity |
GRK6 |
nucleotide binding /// G-protein coupled receptor kinase activity /// protein-tyrosine kinase activity /// signal transducer activity /// ATP binding /// transferase activity /// protein kinase activity /// protein serine/threonine kinase activity /// kinase activity /// receptor activity |
DKK2 |
--- |
TMEM26 |
--- |
WDR68 |
protein binding |
ZFHX1B |
transcription factor activity /// zinc ion binding /// transcriptional repressor activity /// phosphatase regulator activity /// SMAD binding /// metal ion binding /// nucleic acid binding /// DNA binding |
MGC10986 |
zinc ion binding /// metal ion binding |
C21orf37 |
--- |
TRPM2 |
calcium channel activity /// calcium ion binding /// hydrolase activity /// sodium ion binding /// ADP-ribose diphosphatase activity /// ion channel activity /// cation channel activity /// calcium channel activity /// receptor activity |
NIPSNAP3B |
--- |
FHL5 |
zinc ion binding /// metal ion binding |
Cellular Localization Summary
Gene Symbol |
Gene Oontology Cellular Component Description |
RTP1 |
integral to membrane |
CYP3A4 |
membrane fraction /// endoplasmic reticulum /// microsome /// microsome /// cell surface /// membrane /// membrane fraction |
CA12 |
integral to membrane /// integral to membrane |
RABGAP1L |
--- |
NMNAT2 |
--- |
RLTPR |
--- |
CCL5 |
extracellular space /// extracellular region |
GLYAT |
Mitochondrion |
ZC3H12C |
--- |
CEACAM6 |
integral to plasma membrane /// membrane |
AHI1 |
--- |
CYLC1 |
cytoskeleton /// acrosomal matrix /// cytoskeleton |
FLJ20211 |
--- |
AOF2 |
Nucleus |
MGC40368 |
--- |
KIAA0690 |
nucleus /// integral to membrane |
SIRT2 |
chromatin silencing complex /// cytoplasm /// cytoskeleton /// microtubule /// cytoplasm /// microtubule /// chromatin silencing complex /// microtubule |
NUP210 |
integral to membrane /// outer membrane |
OLFM2 |
Membrane |
KIAA0802 |
--- |
STXBP3 |
--- |
ULK1 |
--- |
MGC39558 |
Membrane |
SETBP1 |
Nucleus |
KIAA1609 |
--- |
ZBTB7A |
nucleus /// nucleus |
MAPT |
cytosol /// cytoskeleton /// microtubule /// microtubule associated complex /// plasma membrane /// axon |
ANXA2P3 |
--- |
ZBTB20 |
Nucleus |
FLJ40722 |
--- |
DYM |
integral to membrane |
NEURL |
ubiquitin ligase complex |
OR2A9P /// OR2A20P |
integral to membrane |
CDYL |
chromatin /// nucleus |
STK38 |
nucleus /// nucleus |
ATF7IP2 |
integral to membrane |
MAF |
chromatin /// nucleus |
RP1-32F7.2 |
--- |
DKFZp434D1428 |
--- |
TIFA |
--- |
EVI2B |
integral to plasma membrane |
CH25H |
membrane fraction |
GRK6 |
--- |
DKK2 |
extracellular space /// extracellular region |
TMEM26 |
--- |
WDR68 |
--- |
ZFHX1B |
nucleus /// nucleus |
MGC10986 |
--- |
C21orf37 |
--- |
TRPM2 |
integral to plasma membrane /// membrane /// integral to membrane |
NIPSNAP3B |
--- |
FHL5 |
Nucleus |
Gene Family Summary
Gene Symbol |
Ensembl Family Description |
RTP1 |
RECEPTOR TRANSPORTING |
CYP3A4 |
CYTOCHROME P450 |
CA12 |
|
RABGAP1L |
|
NMNAT2 |
|